The Molecular Diagnostics Core Laboratory is structured to provide key resources for the diagnostic and molecular epidemiological tools that are necessary to implement the projects within this program. The Molecular Diagnostics Core Lab is based at the Hospital Universitario Clemintin Fraga Filho, with a subsidiary lab at the Oswaldo Cruz Foundation. The Core Lab is directed by Leila Fonseca, M.D., Ph.D. and she is assisted by Philip Suffys, Ph.D. The Core Lab is part of the HUFCC Mycobacteriology Reference Lab, which serves as a diagnostic center for the hospital and for Planning Area 1 (AP-1) of the Rio de Janeiro Department of Health. The contributions of the label will be 70% to Project 3, 25% to Project 1 and 5% to Project 2. The lab is well equipped to perform both routine and investigational diagnostic assays for mycobacteria. The personnel of the lab are experienced in the safe handling of infectious specimens and materials. The key investigators and technicians in the Core Lab have considerable experience in molecular diagnostic, serologic assays, DNA fingerprinting, nuclear acid sequencing and solid phase amplification. The lab will maintain strict quality assurance standards that will be codified in operations manuals for all assays performed. The existence of a high quality molecular microbiology laboratory capable of performing cutting-edge technological methods will contribute substantially to the success of this program project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI045432-01
Application #
6227222
Study Section
Special Emphasis Panel (ZAI1-GSM-M (M1))
Project Start
1999-09-15
Project End
2004-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Conde, Marcus B; Mello, Fernanda C Q; Duarte, Rafael Silva et al. (2016) A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis. PLoS One 11:e0154778
Miller, A C; Golub, J E; Cavalcante, S C et al. (2010) Controlled trial of active tuberculosis case finding in a Brazilian favela. Int J Tuberc Lung Dis 14:720-6
Cavalcante, S C; Durovni, B; Barnes, G L et al. (2010) Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 14:203-9
Pacheco, Antonio G; Durovni, Betina; Cavalcante, Solange C et al. (2008) AIDS-related tuberculosis in Rio de Janeiro, Brazil. PLoS One 3:e3132
Guerra, Renata L; Hooper, Nancy M; Baker, James F et al. (2008) Cost-effectiveness of different strategies for amplified Mycobacterium tuberculosis direct testing for cases of pulmonary tuberculosis. J Clin Microbiol 46:3811-2
Dooley, Kelly; Flexner, Charles; Hackman, Judith et al. (2008) Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations. Antimicrob Agents Chemother 52:4037-42
Guerra, Renata L; Baker, James F; Alborz, Roya et al. (2008) Specimen dilution improves sensitivity of the amplified Mycobacterium tuberculosis direct test for smear microscopy-positive respiratory specimens. J Clin Microbiol 46:314-6
Mello, Fernanda C Q; Arias, Mayra S; Rosales, Senia et al. (2007) Clinical evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to isoniazid or rifampin. J Clin Microbiol 45:3387-9
Mendes, Joycenea Matsuda; Fonseca, Leila de Souza; Lourenco, Maria Cristina et al. (2007) A retrospective study of the epidemiological aspects of tuberculosis in the Complexo de Manguinhos, an urban slum area in Rio de Janeiro, Brazil, 2000-2002. J Bras Pneumol 33:443-7
Arias, Mayra; Mello, Fernanda C Q; Pavon, Ada et al. (2007) Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis 44:674-80

Showing the most recent 10 out of 29 publications